PrescriptionDrugs.org

What to Expect When Starting Clonidine

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Clonidine is a centrally acting alpha-2 agonist used to treat hypertension, ADHD (in children and adults), menopausal hot flashes, and opioid withdrawal symptoms. It works by reducing sympathetic nervous system activity, lowering blood pressure and heart rate. While effective, clonidine carries a critical safety risk: abrupt discontinuation can cause dangerous rebound hypertension.

Week-by-week timeline

Day 1-3

Starting Clonidine

Clonidine causes significant sedation in many patients, especially at the start of therapy. This is often the most troublesome side effect. Blood pressure and heart rate decrease within 30-60 minutes of an oral dose. Dry mouth, dizziness, and constipation are common early side effects. For ADHD, the extended-release formulation (Kapvay) is usually taken at bedtime to leverage sedation.

Week 1-2

Sedation Often Improving

Sedation typically decreases over 1-2 weeks as tolerance to this effect develops, while antihypertensive or ADHD benefits are maintained. Do not drive or perform hazardous tasks until you know how clonidine affects your alertness. Blood pressure should be checked regularly.

Week 2-4

Blood Pressure or ADHD Assessment

For hypertension, blood pressure should be consistently lower. For ADHD, improvements in hyperactivity and impulsivity are typically more prominent than improvements in inattention — clonidine is generally more effective for hyperactivity and emotional dysregulation.

Month 1

Dose Optimization

The dose may be titrated gradually (clonidine is started low and increased weekly for ADHD, or titrated more quickly for hypertension). Monitor for constipation, sexual dysfunction, and persistent sedation.

Month 2-3

Long-Term Stability

Consistent blood pressure control or ADHD symptom management should be stable. Do not miss doses — missed doses can cause blood pressure to rebound significantly. Always have a refill plan before running out.

When to call your doctor

Contact your healthcare provider if you experience:

  • Rebound hypertension after missed doses or abrupt discontinuation: sudden severe headache, rapidly rising blood pressure, agitation (seek emergency care)
  • Heart rate below 50 beats per minute
  • Severe dizziness or fainting
  • Significant depression or worsening mood
  • Chest pain or irregular heartbeat
  • Signs of allergic skin reaction with patch formulation: severe rash or blistering
  • Difficulty breathing or facial swelling

Tips for getting started

NEVER stop clonidine abruptly — rebound hypertension is a medical emergency. Always taper under your doctor's guidance. Never miss doses if you can help it; maintain refills proactively. Take clonidine at the same times each day. For the patch formulation, rotate sites and check for skin irritation. Dry mouth is very common — sip water frequently, chew sugarless gum. Avoid alcohol and CNS depressants, which amplify sedation. If you have two doses per day, never miss more than one dose without calling your prescriber.

Frequently asked questions

More about Clonidine

References

  1. [Regulatory] FDA Label: Catapres (clonidine hydrochloride) Tablets https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/017407s023lbl.pdf Accessed 2026-03-01.
  2. [Regulatory] NIH MedlinePlus: Clonidine https://medlineplus.gov/druginfo/meds/a682243.html Accessed 2026-03-01.
  3. [Regulatory] AAP ADHD Guidelines: Non-Stimulant Medications https://publications.aap.org/pediatrics/article/144/4/e20192528/81590/Clinical-Practice-Guideline-for-the-Diagnosis Accessed 2026-03-01.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: